Moreover, incorporating immunohistochemical ASS1 staining into the diagnostic workflow for biopsies and tumor specimens could enhance the personalization of anti-cancer treatments, paving the way for more targeted and effective therapeutic strategies. The gene discussed is ASS1; the disease is cancer.